Abstract: An inverse latex including from 20% to 70% by weight and preferably from 25% to 50% by weight of a branched or crosslinked polyelectrolyte, characterized in that the polyelectrolyte is a copolymer of 2-acrylamido-2-methylpropanesulfonic acid partially or totally salified with acrylamide and optionally one or more monomers chosen from monomers containing a partially or totally salified weak acid function and/or from neutral monomers other than acrylamide, the production process including the control of the pH in the initial aqueous phase; Cosmetic, dermopharmaceutical or pharmaceutical composition including the inverse latex directly obtained by the process.

Abstract: A vaccine adjuvant which, based on the 100% mass thereof, includes between 10% and 95% of a mineral oil containing: between 0.05 mass-% and 10 mass-% hydrocarbon chains having less than 16 carbon atoms, and between 0.05 mass-% and 5 mass-% hydrocarbon chains having more than 28 carbon atoms. In addition, the adjuvant has a P/N ratio, corresponding to the ratio of the mass quantity of the paraffinic hydrocarbon chains to the mass quantity of the naphthenic hydrocarbon chains, of between 2.5 and 3, the adjuvant being intended for the production of a vaccine composition to prevent coccidiosis.

Abstract: A vaccine adjuvant which, based on the 100% mass thereof, includes between 10% and 95% of a mineral oil containing: between 0.05 mass-% and 10 mass-% hydrocarbon chains having less than 16 carbon atoms, and between 0.05 mass-% and 5 mass-% hydrocarbon chains having more than 28 carbon atoms. In addition, the adjuvant has a P/N ratio, corresponding to the ratio of the mass quantity of the paraffinic hydrocarbon chains to the mass quantity of the naphthenic hydrocarbon chains, of between 2.5 and 3, the adjuvant being intended for the production of a vaccine composition to prevent coccidiosis.

Abstract: A method for the treatment of rock formations which may or may not be underground and, more particularly, of oil or gas production wells, water-injection wells intended to flood hydrocarbon (oil or gas) reservoirs or gas mines or gas storage wells includes a step of injecting, into the rock formation or well, a microgel obtained by dilution in water of a self-invertible inverse latex or of a self-invertible inverse microlatex of a crosslinked polyelectrolyte, obtained by copolymerization, in the presence of a crosslinking agent of partially- or totally-salified free 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid, with at least one cationic monomer chosen from: 2,N,N,N-tetramethyl-2-[(1-oxo-2-propenyl)amino]propanammonium chloride; N,N,N-trimethyl-3-[(1-oxo-2-propenyl)amino]propanammonium chloride; diallyldimethylammonium chloride; N,N,N-trimethyl-2-[(1-oxo-2-propenyl)]ethanammonium chloride; N,N,N-trimethyl-2-[(1-oxo-2-methyl-2-propenyl)]ethanammonium chloride; or N,N,N-trimethyl-3-[(1-oxo-2-meth

Abstract: Process for the preparation of a an inverse latex including from 20% to 70% by weight and preferably from 25% to 50% by weight of a branched or crosslinked polyelectrolyte, characterized in that the polyelectrolyte is a copolymer of 2-acrylamido-2-methylpropanesulfonic acid partially or totally salified with acrylamide and optionally one or more monomers chosen from monomers containing a partially or totally salified weak acid function and/or from neutral monomers other than acrylamide, the production process including the control of the pH in the initial aqueous phase; Cosmetic, dermopharmaceutical or pharmaceutical composition including the inverse latex directly obtained by the process.

Abstract: A process for drilling cavities in subterranean formations includes a step of removal of the drill cuttings using an aqueous fluid in the form of a foam, obtained by mixing: an aqueous composition (Ci) including, per 100% by weight: from 0.5% by weight to 25% by weight of a compound of formula (I): R1—C(O)—NH—CH(COOM)-(CH2)n—COOM? (I) in which n represents an integer equal to 1 or 2, R1 represents a linear or branched, saturated or unsaturated aliphatic hydrocarbon-based radical including from eight to eighteen carbon atoms, M represents a monovalent cation and M?, which is identical to or different from M, represents a hydrogen atom or a monovalent cation; or of a mixture of compounds of formula (I), and from 75% to 99.5% by weight of water, with a gas or a mixture of gases, chosen from air, nitrogen or carbon dioxide.

Abstract: A compound having Formula (I), nC7—H15—O-(G)p-H, where G is a reducing sugar residue, and p is a decimal number?1.05 and ?5. The method for preparing the compound and its use as a hydrotropic surfactant by making soluble, in an aqueous alkaline composition, at least one non-ionic surfactant having Formula (II), R—(O—CH(R?)—CH2)n—(0-CH2-CH2)m-0-H, where R is a straight, branched, saturated or unsaturated aliphatic hydrocarbon radical including 8-14 carbon atoms, R? is a methyl or ethyl radical, n and m are whole numbers?0 and ?15, assuming that n+m?0. Cleaning compositions containing 0.5% to 20% of compounds of Formula (I), 0.5% to 80% of compounds of Formula (II), 10-50 wt % of at least one alkaline agent, 15-89 wt % of water, and optionally, 10-50 wt % of at least one anti-limescale agent are useful for cleaning hard surfaces.

Abstract: Process for the preparation of a composition including an oil phase, an aqueous phase, at least one emulsifying system of water-in-oil (W/O) type, optionally at least one emulsifying system of oil-in-water (O/W) type, in the form of an inverse latex including from 20% to 70% by weight and preferably from 25% to 50% by weight of a branched or crosslinked polyelectrolyte, characterized in that the polyelectrolyte is a copolymer of 2-acrylamido-2-methylpropanesulfonic acid partially or totally salified with acrylamide and optionally one or more monomers chosen from monomers containing a partially or totally salified weak acid function and/or from neutral monomers other than acrylamide, the production process being characterized in that the preparation of the aqueous phase includes the dissolution in the aqueous medium of solid 2-acrylamido-2-methyl propanesulfonic acid before neutralization. Cosmetic, dermopharmaceutical or pharmaceutical composition including the inverse latex directly obtained by the process.

Abstract: Process for the preparation of a composition including an oil phase, an aqueous phase, at least one emulsifying system of water-in-oil (W/O) type, optionally at least one emulsifying system of oil-in-water (O/W) type, in the form of an inverse latex including from 20% to 70% by weight and preferably from 25% to 50% by weight of a branched or crosslinked polyelectrolyte, characterized in that the polyelectrolyte is a copolymer of 2-acrylamido-2-methylpropanesulfonic acid partially or totally salified with acrylamide and optionally one or more monomers chosen from monomers containing a partially or totally salified weak acid function and/or from neutral monomers other than acrylamide, the production process being characterized in that the preparation of the aqueous phase includes the dissolution in the aqueous medium of solid 2-acrylamido-2-methyl propanesulfonic acid before neutralization. Cosmetic, dermopharmaceutical or pharmaceutical composition including the inverse latex directly obtained by the process.

Abstract: Polyelectrolyte resulting from polymerization, for 100 mol %, of: a) a molar ratio ?50% and ?99% of monomer units originating from at least one cationic monomer; b) a molar ratio >1% and ?50% of monomer units originating from at least one monomer including a fully or partially salified free weak acid function; c) optionally a molar ratio >0 mol % and ?5 mol % of monomer units originating from at least one monomer of formula A-C(?O)—O—[(CH2—CH(R)—O]n—R (I), where n is, independently, a number from 1 to 50, A is a monovalent unsaturated aliphatic radical having 2 to 6 carbon atoms, R1 is a hydrogen atom, a methyl radical, or an ethyl radical, and R is a linear or branched, saturated or unsaturated aliphatic hydrocarbon radical having 8 to 30 carbon atoms; and d) optionally a molar ratio >0% and ?1% of a diethylene or polyethylene cross-linking monomer.

Abstract: A composition including an oil phase, an aqueous phase, at least one water-in-oil emulsifying system in the form of a positive latex, characterized in that the composition includes a straight, branched, or cross-linked anionic polyelectrolyte, including: a) a non-zero molar proportion of monomer units from acrylic acid in free or partially salified form; and b) a non-zero molar proportion of monomer units from the acid of formula (I): CH2?CH—C(?O)—O—[CH2—CH2—C(?O)—O]n—H??(I), where n is a number greater than or equal to (1) and less than or equal to (5), in free or partially salified form. A method for preparing the same, a polymer powder, and the use thereof as a thickening agent for cosmetic or pharmaceutical compositions are also described.

Abstract: The oil-in-water cosmetic topical emulsion contains: (1) 95 to 50 wt % of an aqueous phase (P1); and (2) 5 to 50 wt % of a fatty phase (P2), wherein the fatty phase (P2) particularly includes: 0.2 to 60 wt %, specifically 2 to 20 wt %, of at least one N-acylated amino acid derivative of formula (I): R1-C(?O)—NH—CH— (R?1)—C(?O)—OH (I), where R1 is a saturated or unsaturated, straight or branched, aliphatic hydrocarbon radical having seven to seventeen carbon atoms, and R?1 is a hydrogen atom or a hydrocarbon radical selected from among methyl, benzyl, isopropyl, 1-methylpropyl, or isobutyl radicals. The method for preparing the oil-in-water cosmetic topical emulsion is also described.

Abstract: A novel composition made of polyalkoxylated derivatives of trimethylolpropane and fatty alcohols, the composition lending itself to the preparation thereof and to the use thereof as a reversing agent for a reversible reverse latex.

Abstract: A method for preparing an injectable vaccine composition intended to combat porcine reproductive and respiratory syndrome (PRRS), includes at least the step in which: a) a live vaccine is mixed extemporaneously with an adjuvant diluent (AD). The adjuvant diluent is an oil-in-water-type emulsion or an oil-in-water-type microemulsion, or an aqueous solution including water and at least one inorganic salt selected from aluminum hydroxide, cerium nitrate, zinc sulfate, colloidal iron hydroxide or calcium chloride, salts of divalent or trivalent metals or sympathomimetic compounds.

Abstract: A method for preparing a vaccine composition to be implemented in a locally administered treatment for avian viral disease, includes at least the step of: a) extemporaneously mixing a vaccine, including at least one live virus selected from a virus belonging to one or more strains of the avian disease, with an adjuvant diluent (DA), characterized in that the adjuvant diluent is a continuous aqueous phase oil-in-water emulsion or oil-in-water microemulsion.

Abstract: A vaccine adjuvant which, based on the 100% mass thereof, includes between 10% and 95% of a mineral oil containing: between 0.05 mass-% and 10 mass-% hydrocarbon chains having less than 16 carbon atoms, and between 0.05 mass-% and 5 mass-% hydrocarbon chains having more than 28 carbon atoms. In addition, the adjuvant has a P/N ratio, corresponding to the ratio of the mass quantity of the paraffinic hydrocarbon chains to the mass quantity of the naphthenic hydrocarbon chains, of between 2.5 and 3, the adjuvant being intended for the production of a vaccine composition to prevent coccidiosis.

Abstract: A compound of the formula (I): where m is an integer equal to 0 or 1, and p is an integer equal to 0, 1, 2 or 3. A method for preparing the compound of the formula (I), and the use thereof as a skin lightening agent. A cosmetic composition and a drug containing the compound of the formula (I).

Abstract: A method for restructuring the epidermis with a composition, wherein said composition includes a polyol-glycoside and said polyol-glycoside is obtained by the acetalization of a polyol with a reducing sugar.

Abstract: Disclosed is a branched or crosslinked anionic polyelectrolyte of at least one monomer having a partially- or totally-salified strong acid function, with at least one neutral monomer and at least one monomer having formula (I), wherein: R represents a linear or branched alkyl radical including between 8 and twenty carbon atoms, and n represents a number greater than or equal to 1 and less than or equal to twenty. Also described is the use thereof as a thickener in topical compositions.

Abstract: A composition in the form of a positive latex includes: a) 50-80 wt. % of at least one cross-linked, branched, or linear organic polymer (P), b) 5-10 wt. % of a water-in-oil (W/O) emulsifying system (S1), c) 5-45 wt. % of at least one oil, and d) 0-5 wt. % of water. Between 0.01 mol. % and 10 mol. % of the monomeric patterns of the monomer P include at least one neutral monomer of formula (I): C(R1)(R3)?C(R2)—C(?O)—O—(CH2—CH2—O)n—R4 (I) wherein the radicals R1, R2 and R3, which are the same or different, independently represent a hydrogen atom or a linear or branched alkyl radical including between 1 and 4 carbon atoms, the radical R4 represents a linear or branched, saturated or unsaturated, aliphatic radical including between 6 and 30 carbon atoms, and n represents a number between 1 and 50. A production method and use are also described.